Significantly higher ectopic HER2-positive tumor-to-blood ratios than ectopic melanoma ratios were observed from 24 h (p < 0.05), but the difference was not significant using tumor-to-muscle-ratios (Figure 4). The gene discussed is ERBB2; the disease is neoplasm.